A potent neutralizing mouse monoclonal antibody specific to dengue virus type 1 Mochizuki strain recognized a novel epitope around the N-67 glycan on the envelope protein: A possible explanation of dengue virus evolution regarding the acquisition of N-67 glycan-Reference-Cited by-同舟云学术

A potent neutralizing mouse monoclonal antibody specific to dengue virus type 1 Mochizuki strain recognized a novel epitope around the N-67 glycan on the envelope protein: A possible explanation of dengue virus evolution regarding the acquisition of N-67 glycan

Published:2021-03 Issue: Volume:294 Page:198278
ISSN:0168-1702
Container-title:Virus Research
language:en
Short-container-title:Virus Research

Author:

Kotaki Tomohiro,Yamanaka Atsushi,Konishi Eiji,Kameoka Masanori^ORCID

Funder

Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Cancer Research,Infectious Diseases,Virology

Reference47 articles.

1. The impact of the newly licensed dengue vaccine in endemic countries;Aguiar;PLoS Negl. Trop. Dis.,2016

2. Mutational evidence for an internal fusion peptide in flavivirus envelope protein;Allison;J. Virol.,2001

3. The global distribution and burden of dengue;Bhatt;Nature,2013

4. A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice;Block;Vaccine,2010

5. Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes;Bryant;Virology,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation and therapeutic efficacy of the novel Fc-modified cross-neutralizing human monoclonal antibodies against dengue virus;2023-05-26

2. Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection;Vaccines;2022-08-28